Pall Corporation, incorporated in July 1946, and its subsidiaries is a leading
supplier of fine filters, principally made by the Company using its proprietary
filter media, and other fluid clarification and separations equipment for the
removal of solid, liquid and gaseous contaminants from a wide variety of liquids
and gases.
We serve customers in two principal markets: Life Sciences and Industrial.
The two principal markets are further divided into five segments: Medical and
BioPharmaceuticals (which comprise the Life Sciences business) and General Industrial,
Aerospace and Microelectronics (which comprise the Industrial business).
We are a specialty materials and engineering company with the broadest-based
filtration, separations and purification capabilities in the world. Our proprietary
products are used to discover, develop and produce pharmaceuticals, produce
safe drinking water, protect hospital patients, remove white blood cells from
blood, enhance the quality and efficiency of manufacturing processes, keep equipment
running efficiently and protect the environment. Requirements for product quality,
purity, environmental preservation, health and safety apply to a wide range
of industries and across geographic borders. We have a 57-year history of commercializing
successful products and continue to develop new materials and technologies for
the Life Sciences and Industrial markets and their increasingly difficult fluid
filtration, purification and separation challenges. We have an array of core
materials and technologies that can be combined and manipulated in many ways
to solve complex fluid separation challenges. These proprietary materials, coupled
with our ability to engineer them into useful forms, are the cornerstones of
our capabilities. Our proprietary materials enable us to provide customers with
products that are well matched to their needs, to develop new products and to
enter new markets. With the addition of FSG, we enhanced our library of proprietary
materials and technologies with sophisticated offerings such as asymmetric membranes,
selective adsorption, melt-blown media, nano ceramic membranes and metallic
fiber media.
We actively pursue only those applications in which Pall products can make
a substantial difference to the customer and especially target projects that
will result in real gains in performance and economics. The products sold are
principally filters made with proprietary Pall filter media produced by chemical
film casting, melt-blowing of polymer fibers, papermaking and metallurgical
processes. Metal and plastic housings for our filters and a wide variety of
appurtenant devices are also made. Competition is intense in all of our markets
and includes many large and small companies in our global markets; however,
no one company has a significant presence in all of our markets.
Most raw materials used by the Company are available from multiple sources.
A limited number of materials are proprietary products of major chemical companies.
The Company believes that it could find satisfactory substitutes for these materials
should they become unavailable, as it has done several times in the past.
Our principal competitors in the Medical segment include Baxter, Asahi Medical,
MacoPharma, Terumo and Fresenius, and our principal competitors in the BioPharmaceuticals
segment include Millipore, Sartorius and CUNO.
Competition varies by product, and no single competitor competes with us across
all sub-segments of Aerospace; however, our principal competitors include Donaldson,
ESCO Technologies Inc. and CLARCOR.
The principal competitors in the Microelectronics market include Mykrolis and
Mott.
0.94% 